Medtronic plc. (MDT) New York Stock Exchange
86.031.281.51%
CloseJanuary 15, 2019

News: updated – 16-Jan 01:33


Goldman likes Incyte in premarket analyst action15-Jan 08:38(SeekingAlpha)

Array BioPharma (NASDAQ: ARRY ) initiated with Overweight rating and $30 (76% upside) price target. Shares are up 9% premarket on late-stage Mektovi/Braftovi data. More news on: Array BioPharma Inc., Incyte Corporation, Mednax, Inc., Healthcare stocks news, Stocks on the move, …